Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial. - Kang G; Abdalla S; Parfrey PS; Lopes RD; Patel UD; London G; Chertow GM; Mahaffey KW (American journal of nephrology, 2026)